PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
about
PPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Telmisartan ameliorates fibrocystic liver disease in an orthologous rat model of human autosomal recessive polycystic kidney diseaseEffects of p-CREB-1 on transforming growth factor-β3 auto-regulation in hepatic stellate cellsTGF-beta1 blockade of microglial chemotaxis toward Abeta aggregates involves SMAD signaling and down-regulation of CCL5Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverAnti-fibrogenic effect of PPAR-γ agonists in human intestinal myofibroblasts.Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injuryHepatic stellate cells and parasite-induced liver fibrosis.Nitrated fatty acids reverse pulmonary fibrosis by dedifferentiating myofibroblasts and promoting collagen uptake by alveolar macrophages.Is peroxisome proliferator-activated receptor gamma (PPARγ) a therapeutic target for the treatment of pulmonary hypertension?Simvastatin ameliorates liver fibrosis via mediating nitric oxide synthase in rats with non-alcoholic steatohepatitis-related liver fibrosisHypoxia-induced inhibition of lung development is attenuated by the peroxisome proliferator-activated receptor-γ agonist rosiglitazone.Nanoscale hepatoprotective herbal decoction attenuates hepatic stellate cell activity and chloroform-induced liver damage in mice.The PPARγ Agonist Rosiglitazone Is Antifibrotic for Scleroderma Lung Fibroblasts: Mechanisms of Action and Differential Racial Effects.Hyperoxia-induced neonatal rat lung injury involves activation of TGF-{beta} and Wnt signaling and is protected by rosiglitazoneThe Role of PPARs in Lung Fibrosis.Peroxisome proliferator-activated receptor γ: innate protection from excessive fibrogenesis and potential therapeutic target in systemic sclerosisRegulation of Matrix Remodeling by Peroxisome Proliferator-Activated Receptor-γ: A Novel Link Between Metabolism and Fibrogenesis.Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.Troglitazone suppresses transforming growth factor beta-mediated fibrogenesis in retinal pigment epithelial cells.Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines.The anti-fibrotic effect of bone morphogenic protein-7(BMP-7) on liver fibrosisAgonists at PPAR-gamma suppress angiotensin II-induced production of plasminogen activator inhibitor-1 and extracellular matrix in rat cardiac fibroblastsA Novel Mechanism of PPARgamma Regulation of TGFbeta1: Implication in Cancer BiologyRole of methionine adenosyltransferase α2 and β phosphorylation and stabilization in human hepatic stellate cell trans-differentiationGlobal analysis of in vivo Foxa2-binding sites in mouse adult liver using massively parallel sequencingMechanisms of Lung Fibrosis Resolution.Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?Nuclear receptors in macrophages: a link between metabolism and inflammation.PPARs Mediate Lipid Signaling in Inflammation and Cancer.15-deoxy-Δ12,14 -prostaglandin J 2 Down-Regulates Activin-Induced Activin Receptor, Smad, and Cytokines Expression via Suppression of NF- κ B and MAPK Signaling in HepG2 CellsAsiatic acid isolated from Centella asiatica inhibits TGF-β1-induced collagen expression in human keloid fibroblasts via PPAR-γ activation.Peroxisome proliferator-activated receptor-gamma abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator.Curcumin Suppresses Intestinal Fibrosis by Inhibition of PPARγ-Mediated Epithelial-Mesenchymal TransitionThe interaction between HCV and nuclear receptor-mediated pathwaysElectrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts.The Role of PPAR Gamma in Systemic Sclerosis.The stellate cell system (vitamin A-storing cell system).Side population in LX2 cells decreased by transforming growth factor-β.
P2860
Q24633440-40B90FB8-5C8B-4124-9D46-7A1790BE0A9DQ28536366-6BA0DE10-2A10-442B-A4D9-A11A41FCBD10Q28564900-F4C4887B-A086-42F5-85BC-75320AD95CC3Q28568787-D49987B1-D485-40C8-BE82-0FEE918692E5Q29616840-9A1B755A-A4AF-4E9B-AED2-0868B8FC4DBCQ33776469-43B899F6-5597-40CA-A828-D3844B5CCFEDQ33840489-8E45D171-7FFD-4221-A7DD-7C5A9729290EQ34043746-C81F8502-1D75-46CE-927C-DE680FDF128AQ34512881-85BDC2C9-FE49-44CC-83CD-A4396E053AC4Q34897476-E5A5D2BD-840F-4F8F-AB91-65C7889D37D0Q35009517-5E06357D-3F08-4779-A46B-20C72EE3A84BQ35087009-3455791A-E861-4BBC-B492-6A9C00B4BCE4Q35097031-27C1881B-99BF-4FCE-8B58-3EF220419EC3Q35503543-1CE5D20F-025C-4977-B7E1-80826E7D5C3EQ35776531-B9BF7E26-DC0D-49B5-B758-2644DB1FC58DQ35925362-66D69B68-3371-4234-BAA6-CDE430C9330DQ35954579-FC5F3DBF-1E06-4BCE-96A4-F02276C24695Q36093802-4E139699-5E66-47A0-BA16-9A4F94F1CE92Q36282521-2FD88D71-EF47-44F9-86FB-B833498C8DAFQ36478992-AD459055-7636-4479-8879-4003C799A635Q36479876-22FEBF06-42D7-4F70-A76D-D1B10A245E79Q36605155-98B7BBB3-8526-47F8-BBCC-F43953A508FFQ36663411-01BE7B5B-2861-4AE9-9547-BAA6ABC416D3Q36734442-090EC328-20E9-4C95-BA0E-E47B6D0B7859Q36743890-C86419AE-F5D3-4815-864A-87FAFACBDABEQ36820956-1C0AD445-9ED9-4B62-A7DE-5B1FC4A12262Q36824035-82BFCADC-499E-425C-BC94-E8E509FAB4FFQ36885732-FDC89AE4-9D9D-432A-9530-690A08E4EF35Q36924390-83AD1002-7743-4D2C-A72B-CCE7A73C1CECQ37005645-079EE55E-5178-4CA8-A2C7-C04B1C3AEA9BQ37021709-7363F217-E6BA-4C9E-BF83-B1CE97599A0EQ37239632-7D2AFC72-90A4-4913-AEA9-8CEFE577167CQ37317161-6E2548F6-BC43-45FB-BE67-6312ADEE2277Q37326935-391AF0B5-A377-47FF-9547-9E611A109D1EQ37624991-0F05A58A-0324-40C7-9042-0A07146DA333Q37881205-850F7D05-481F-44FE-A8D3-527B8526D968Q38355897-EC916CD2-5649-46EF-941C-1EF7073AC767Q38524619-D58BD74E-E660-4E6B-9050-D859718D1D33Q38744473-86D35A21-01F7-4912-B623-7D90B8DA7888Q39167934-BB57B586-C454-496D-A940-E74C2BEECAAD
P2860
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
@en
type
label
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
@en
prefLabel
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
@en
P2093
P2860
P1476
PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells.
@en
P2093
Anna Mae Diehl
Caiyan Zhao
Lihong Chen
Stephen A Stimpson
P2860
P304
P356
10.1016/J.BBRC.2006.09.069
P577
2006-09-22T00:00:00Z